Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck's $303 Million Ambryx Deal Great For Investors
Merck's $303 Million Ambryx Deal Great For Investors
Merck's $303 Million Ambryx Deal Great For Investors
Submitted by
admin
on June 28, 2012 - 6:03pm
Source:
Seeking Alpha
News Tags:
Merck
Ambryx
AstraZeneca
GSK
Novartis
Pfizer
Palatin
Headline:
Merck's $303 Million Ambryx Deal Great For Investors
Do Not Allow Advertisers to Use My Personal information
